Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Study of BN301, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies
ClinicalTrials.gov study NCT05611853. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma
ClinicalTrials.gov study NCT06987916. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT05633615. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B
ClinicalTrials.gov study NCT04357600. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-CD22 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy for Relapsed Refractory B-cell Malignancies
ClinicalTrials.gov study NCT04007978. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate MK-1045 (CN201) in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (MK-1045-001/CN201-101)
ClinicalTrials.gov study NCT06189391. IPD Sharing: YES. Countries: 1. Publications: 0.
Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) for the Treatment of Intermediate or High Grade B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05801913. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of TQ-B3525 in Subjects With Relapse/Refractory Diffuse Large B-cell Lymphoma （DLBCL）
ClinicalTrials.gov study NCT04610970. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Tyrosine Kinase Inhibitor Orelabrutinib (ICP-022) in Patients With r/r B-Cell Malignancies
ClinicalTrials.gov study NCT04014205. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Investigations Regarding B-cell Subsets in Humans
ClinicalTrials.gov study NCT00926692. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Thrombosis in Diffuse Large B-cell Lymphoma:the PREDIC-TO (PREDICt ThrOmbosis) Study
ClinicalTrials.gov study NCT06694779. IPD Sharing: NO. Countries: 1. Publications: 0.
Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia
ClinicalTrials.gov study NCT05429905. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)
ClinicalTrials.gov study NCT06294236. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of BKM120 & Rituximab in Patients With Relapsed or Refractory Indolent B-Cell Lymphoma
ClinicalTrials.gov study NCT02049541. IPD Sharing: NO. Countries: 1. Publications: 0.
CAR-T CD19/CD20 for Patients With Advanced CD19/CD20+ B Cell Line Recurrent or Refractory Hematological Malignancies
ClinicalTrials.gov study NCT04700319. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Welgenaleucel (UWC19) in Patients With Relapsed or Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT04296461. IPD Sharing: Not stated. Countries: 1. Publications: 0.
UBX-303061 in Subjects With Relapsed/Refractory B-Cell Malignancies
ClinicalTrials.gov study NCT06590961. IPD Sharing: NO. Countries: 3. Publications: 0.
NKTR-255 vs Placebo Following CD19-directed CAR-T Therapy in Patients With Relapsed/Refractory Large B-cell Lymphoma
ClinicalTrials.gov study NCT05664217. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/II Study of CM355 in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)
ClinicalTrials.gov study NCT05210868. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of CT-RD06 Cell Injection in Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancy
ClinicalTrials.gov study NCT04226989. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.